For the full presentation, downloadable Practice Aids, slides, and complete NCPD/ILNA/AAPA information, and to apply for credit, please visit us at PeerView.com/USZ865. NCPD/ILNA/AAPA credit will be available until May 8, 2025.
Nurses at the Forefront of Maximizing the Potential of TROP2-Targeted Therapy in TNBC and HR+, HER2- Breast Cancer: Best Practices for Adverse Event Management and Patient Education
In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, GRASP, and The Chrysalis Initiative. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by an independent educational grant from Gilead Sciences, Inc.
Disclosure information is available at the beginning of the video presentation.
View all episodes
By PVI, PeerView Institute for Medical Education
4
1010 ratings
For the full presentation, downloadable Practice Aids, slides, and complete NCPD/ILNA/AAPA information, and to apply for credit, please visit us at PeerView.com/USZ865. NCPD/ILNA/AAPA credit will be available until May 8, 2025.
Nurses at the Forefront of Maximizing the Potential of TROP2-Targeted Therapy in TNBC and HR+, HER2- Breast Cancer: Best Practices for Adverse Event Management and Patient Education
In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, GRASP, and The Chrysalis Initiative. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by an independent educational grant from Gilead Sciences, Inc.
Disclosure information is available at the beginning of the video presentation.
134 Listeners
320 Listeners
498 Listeners
40 Listeners
27 Listeners
10 Listeners
5 Listeners
10 Listeners
4 Listeners
2 Listeners
5 Listeners
2 Listeners
3 Listeners
5 Listeners
5 Listeners
2 Listeners
0 Listeners
9 Listeners
2 Listeners
115 Listeners
2 Listeners
4 Listeners
57 Listeners
3 Listeners
5 Listeners
3,336 Listeners
44 Listeners
22 Listeners
2 Listeners
365 Listeners
54 Listeners
58 Listeners
189 Listeners